Relationship between Prosthesis-Patient Mismatch and Pro-Brain Natriuretic Peptides after Aortic Valve Replacement

被引:0
作者
Melina, Giovanni [1 ]
Angeloni, Emiliano [1 ]
Benedetto, Umberto [1 ]
Refice, Simone [1 ]
Miele, Antonio [1 ]
Miele, Cristina [2 ]
Ciavarella, Giuseppino M. [2 ]
Sinatra, Riccardo [1 ]
机构
[1] Univ Roma La Sapienza, Policlin S Andrea, Dept Cardiac Surg, I-00189 Rome, Italy
[2] Univ Roma La Sapienza, Policlin S Andrea, Dept Cardiol, I-00189 Rome, Italy
关键词
EFFECTIVE ORIFICE AREA; LONG-TERM SURVIVAL; STENOSIS; IMPACT; SIZE; MORTALITY; DISEASE; ASSOCIATION; AGE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of the study: It has been shown previously that elevated plasma levels of B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-pro-BNP) are related to the degree and progression of native aortic valve disease. In addition, NT-pro-BNP levels have been shown to decrease after successful aortic valve replacement (AVR). The presence of a valve prosthesis-patient mismatch (PPM) may affect the beneficial effects of AVR, however. The study aim was to investigate the relationship between PPM and NT-pro-BNP plasma levels late after AVR. Methods: A series of consecutive patients (42 males, 31 females; mean age 66 13 years) who had undergone isolated AVR between May 2004 and July 2007 was enrolled into the study. Patients with preoperative moderate to severe mitral regurgitation, coronary artery disease, left ventricular (LV) dysfunction (ejection fraction <45%) and serum creatinine >150 mmol/l were excluded. PPM was defined severe as an indexed effective orifice area (EOAi) <= 0.65cm(2)/m(2), or moderate when the EOAi was 0.66-0.85 cm(2)/m(2). Plasma NT-pro-BNP levels and echocardiographic assessments were performed in all patients during routine follow up after surgery. Results: The patients received either a biological (n = 42) or mechanical (n = 31) prosthesis. Among the patients, 21 had no PPM, 27 moderate PPM, and 25 severe PPM. At a median follow up of 18 months, the mean NT-pro-BNP plasma level was 532 pg/ml (95% CI: 393.1-671.6), and the mean LV mass index (LVMI) 120 +/- 4 g/m(2), the LVEF 60 +/- 1%, the peak aortic prosthesis gradient 28 +/- 2 mmHg, and the EOAi 0.74 +/- 0.02 cm(2)/m(2). Multivariate statistical analysis showed that NT-pro-BNP level correlated with age (beta = 0.57, p <0.0001), LVMI (beta = 0.32, p = 0.02), NYHA class (beta = 0.50, p = 0.003) and EOAi (beta = -0.38, p = 0.02). Conclusion: The study results showed that NT-pro-BNP levels were independently related to PPM late after isolated AVR in patients with preserved LV function. However, further investigations are required to confirm these findings and to identify their clinical implications.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [1] Predictors and Outcomes of Prosthesis-Patient Mismatch After Aortic Valve Replacement
    Dayan, Victor
    Vignolo, Gustavo
    Soca, Gerardo
    Paganini, Juan Jose
    Brusich, Daniel
    Pibarot, Philippe
    JACC-CARDIOVASCULAR IMAGING, 2016, 9 (08) : 924 - 933
  • [2] Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
    Herrmann, Howard C.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (21) : 2183 - 2185
  • [3] Impact of prosthesis-patient mismatch on early haemodynamic status after aortic valve replacement
    Kindo, Michel
    Minh, Tam Hoang
    Perrier, Stephanie
    Petit-Eisenmann, Helene
    Bentz, Jonathan
    Cristinar, Mircea
    Ajob, Gharib
    Collange, Olivier
    Mazzucotelli, Jean-Philippe
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2017, 24 (01) : 48 - 54
  • [4] Prosthesis-Patient Mismatch After "High-Risk" Aortic Valve Replacement
    Popma, Jeffrey J.
    Khabbaz, Kamal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (13) : 1335 - 1338
  • [5] Prosthesis-Patient Mismatch in the Transcatheter Aortic Valve Replacement Era
    Tuzcu, E. Murat
    Oezkan, Alper
    Kapadia, Samir R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (18) : 1919 - 1922
  • [6] Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry
    Ternacle, Julien
    Pibarot, Philippe
    Herrmann, Howard C.
    Kodali, Susheel
    Leipsic, Jonathon
    Blanke, Philipp
    Jaber, Wael
    Mack, Michael J.
    Clavel, Marie-Annick
    Salaun, Erwan
    Guzzetti, Ezequiel
    Annabi, Mohamed-Salah
    Bernier, Mathieu
    Beaudoin, Jonathan
    Khalique, Omar K.
    Weissman, Neil J.
    Douglas, Pamela
    Bax, Jeroen
    Dahou, Abdellaziz
    Xu, Ke
    Alu, Maria
    Rogers, Erin
    Leon, Martin
    Thourani, Vinod H.
    Abbas, Amr E.
    Hahn, Rebecca T.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (13) : 1466 - 1477
  • [7] Impact of prosthesis-patient mismatch on early and late mortality after aortic valve replacement
    Koene, Bart M.
    Hamad, Mohamed A. Soliman
    Bouma, Wobbe
    Mariani, Massimo A.
    Peels, Kathinka C.
    van Dantzig, Jan-Melle
    van Straten, Albert H.
    JOURNAL OF CARDIOTHORACIC SURGERY, 2013, 8
  • [8] The Incidence and Consequence of Prosthesis-Patient Mismatch After Surgical Aortic Valve Replacement
    Fallon, John M.
    DeSimone, Joseph P.
    Brennan, J. Matthew
    O'Brien, Sean
    Thibault, Dylan P.
    DiScipio, Anthony W.
    Pibarot, Philippe
    Jacobs, Jeffrey P.
    Malenka, David J.
    Clarizia, Nadia A.
    Ruel, Marc
    ANNALS OF THORACIC SURGERY, 2018, 106 (01) : 14 - 23
  • [9] Overcoming prosthesis-patient mismatch with transcatheter aortic valve replacement
    Grubb, Kendra J.
    Tom, Stephanie K.
    Sultan, Ibrahim
    Sa, Michel Pompeu
    ANNALS OF CARDIOTHORACIC SURGERY, 2024, 13 (03) : 236 - 243
  • [10] Prosthesis-patient mismatch in transcatheter aortic valve replacement
    Grubb, Kendra J.
    Kalra, Kanika
    Tom, Stephanie K.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2025, 72 : 31 - 33